CCI
CLVS

Columbus Circle Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Columbus Circle Investors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-213,674
Closed -$17.6M – 289
2017
Q3 		$17.6M Buy
213,674
+91,142
+74% +$7.23M 0.3% 101
2017
Q2 		$11.5M Buy
122,532
+66,713
+120% +$4.08M 0.19% 118
2017
Q1 		$3.55M Buy
+55,819
New +$3.39M 0.05% 208
2016
Q4 		– Sell
-6,337
Closed -$228K – 310
2016
Q3 		$228K Buy
+6,337
New +$136K ﹤0.01% 270
2015
Q1 		– Sell
-24,461
Closed -$1.37M – 335
2014
Q4 		$1.37M Sell
24,461
-165,885
-87% -$8.72M 0.01% 254
2014
Q3 		$8.63M Buy
190,346
+129,068
+211% +$5.39M 0.06% 197
2014
Q2 		$2.54M Buy
61,278
+50,108
+449% +$2.58M 0.02% 244
2014
Q1 		$774K Buy
+11,170
New +$820K 0.01% 273

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Columbus Circle Investors's CLVS Position: Q4 2017 in Review

Columbus Circle Investors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 213,674 shares — an estimated $17.6M sold.

Columbus Circle Investors first reported a position in CLVS in Q1 2014 and held it in 8 quarters. The position peaked at $17.6M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Columbus Circle Investors reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 213,674 Clovis Oncology, Inc. shares in Q4 2017, an estimated $17.6M.
  • Columbus Circle Investors first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 8 quarters.
  • Columbus Circle Investors's Clovis Oncology, Inc. position peaked at $17.6M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.